These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 35770415)

  • 1. An Overview on Immunity Booster Foods in Coronavirus Disease (COVID-19).
    Sahiba N; Sethiya A; Agarwal DK; Agarwal S
    Comb Chem High Throughput Screen; 2023; 26(7):1251-1284. PubMed ID: 35770415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
    Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
    mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural Products: A Rich Source of Antiviral Drug Lead Candidates for the Management of COVID-19.
    Wijayasinghe YS; Bhansali P; Viola RE; Kamal MA; Poddar NK
    Curr Pharm Des; 2021; 27(33):3526-3550. PubMed ID: 33213322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An overview of potential therapeutic agents to treat COVID-19.
    Dong X; Tian Z; Shen C; Zhao C
    Biosci Trends; 2020 Nov; 14(5):318-327. PubMed ID: 33100290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Traditional herbs against COVID-19: back to old weapons to combat the new pandemic.
    Al-Kuraishy HM; Al-Fakhrany OM; Elekhnawy E; Al-Gareeb AI; Alorabi M; De Waard M; Albogami SM; Batiha GE
    Eur J Med Res; 2022 Sep; 27(1):186. PubMed ID: 36154838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral Essential Oils Incorporated in Nanocarriers: Strategy for Prevention from COVID-19 and Future Infectious Pandemics.
    Kaur M; Devi G; Nagpal M; Singh M; Dhingra GA; Aggarwal G
    Pharm Nanotechnol; 2020; 8(6):437-451. PubMed ID: 33069206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention and treatment of COVID-19 disease by controlled modulation of innate immunity.
    Schijns V; Lavelle EC
    Eur J Immunol; 2020 Jul; 50(7):932-938. PubMed ID: 32438473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening a Library of FDA-Approved and Bioactive Compounds for Antiviral Activity against SARS-CoV-2.
    Biering SB; Van Dis E; Wehri E; Yamashiro LH; Nguyenla X; Dugast-Darzacq C; Graham TGW; Stroumza JR; Golovkine GR; Roberts AW; Fines DM; Spradlin JN; Ward CC; Bajaj T; Dovala D; Schulze-Gamen U; Bajaj R; Fox DM; Ott M; Murthy N; Nomura DK; Schaletzky J; Stanley SA
    ACS Infect Dis; 2021 Aug; 7(8):2337-2351. PubMed ID: 34129317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug Discovery of Small Molecules for the Treatment of COVID-19: A Review on Clinical Studies.
    Goel B; Bhardwaj N; Tripathi N; Jain SK
    Mini Rev Med Chem; 2021; 21(12):1431-1456. PubMed ID: 33371848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propolis and its potential against SARS-CoV-2 infection mechanisms and COVID-19 disease: Running title: Propolis against SARS-CoV-2 infection and COVID-19.
    Berretta AA; Silveira MAD; Cóndor Capcha JM; De Jong D
    Biomed Pharmacother; 2020 Nov; 131():110622. PubMed ID: 32890967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The FDA-Approved Drug Cobicistat Synergizes with Remdesivir To Inhibit SARS-CoV-2 Replication
    Shytaj IL; Fares M; Gallucci L; Lucic B; Tolba MM; Zimmermann L; Adler JM; Xing N; Bushe J; Gruber AD; Ambiel I; Taha Ayoub A; Cortese M; Neufeldt CJ; Stolp B; Sobhy MH; Fathy M; Zhao M; Laketa V; Diaz RS; Sutton RE; Chlanda P; Boulant S; Bartenschlager R; Stanifer ML; Fackler OT; Trimpert J; Savarino A; Lusic M
    mBio; 2022 Apr; 13(2):e0370521. PubMed ID: 35229634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective inhibition of coronavirus replication by
    Xu H; Li J; Song S; Xiao Z; Chen X; Huang B; Sun M; Su G; Zhou D; Wang G; Hao R; Wang N
    Front Biosci (Landmark Ed); 2021 Oct; 26(10):789-798. PubMed ID: 34719206
    [No Abstract]   [Full Text] [Related]  

  • 13. [Diagnosis, treatment, control and prevention of SARS-CoV-2 and coronavirus disease 2019: back to the future].
    Ye ZW; Jin DY
    Sheng Wu Gong Cheng Xue Bao; 2020 Apr; 36(4):571-592. PubMed ID: 32347053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Old Drugs for a New Virus: Repurposed Approaches for Combating COVID-19.
    Saul S; Einav S
    ACS Infect Dis; 2020 Sep; 6(9):2304-2318. PubMed ID: 32687696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural Understanding of SARS-CoV-2 Drug Targets, Active Site Contour Map Analysis and COVID-19 Therapeutics.
    Selvaraj C; Dinesh DC; Krafcikova P; Boura E; Aarthy M; Pravin MA; Singh SK
    Curr Mol Pharmacol; 2022; 15(2):418-433. PubMed ID: 34488601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanisms and epidemiology of COVID-19 from an allergist's perspective.
    Hosoki K; Chakraborty A; Sur S
    J Allergy Clin Immunol; 2020 Aug; 146(2):285-299. PubMed ID: 32624257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a Fluorescence-Based, High-Throughput SARS-CoV-2 3CL
    Froggatt HM; Heaton BE; Heaton NS
    J Virol; 2020 Oct; 94(22):. PubMed ID: 32843534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-SARS-CoV-2 Potential of Artemisinins In Vitro.
    Cao R; Hu H; Li Y; Wang X; Xu M; Liu J; Zhang H; Yan Y; Zhao L; Li W; Zhang T; Xiao D; Guo X; Li Y; Yang J; Hu Z; Wang M; Zhong W
    ACS Infect Dis; 2020 Sep; 6(9):2524-2531. PubMed ID: 32786284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): a global pandemic and treatment strategies.
    Sharma A; Tiwari S; Deb MK; Marty JL
    Int J Antimicrob Agents; 2020 Aug; 56(2):106054. PubMed ID: 32534188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current therapies under investigation for COVID-19: potential COVID-19 treatments.
    Weisberg E; Sattler M; Yang PL; Parent A; Gray N; Griffin JD
    Can J Physiol Pharmacol; 2020 Aug; 98(8):483-489. PubMed ID: 32640179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.